OSE Immunotherapeutics SA (OSE.PA)

EUR 7.17

(-1.38%)

Annual Balance Sheets

(In EUR)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 81.9 Million 91.67 Million 101.52 Million 96.84 Million 88.89 Million 76.9 Million
Total Current Assets 30.47 Million 37.2 Million 44.2 Million 39.83 Million 33.06 Million 23.02 Million
Cash And Short Term Investments 18.67 Million 25.62 Million 33.57 Million 29.36 Million 25.84 Million 12.43 Million
Cash and Cash Equivalents 18.67 Million 25.62 Million 33.57 Million 29.36 Million 25.84 Million 9.57 Million
Short Term Investments - - - - - 2.86 Million
Net Receivables 9.06 Million 8.12 Million 7.66 Million 7.96 Million 5.43 Million 2.25 Million
Inventory - - - - - -
Other Current Assets 2.74 Million 3.45 Million 2.96 Million 2.49 Million 1.78 Million 8.33 Million
Total Non-Current Assets 51.42 Million 54.47 Million 57.31 Million 57.01 Million 55.82 Million 904 Thousand
Net PPE 4.07 Million 4.97 Million 5.43 Million 3.79 Million 2.7 Million 904 Thousand
Good Will And Intangible Assets 46.4 Million 48.78 Million 51.12 Million 52.6 Million 52.6 Million 52.6 Million
Good Will - - - - - -
Intangible Assets 46.4 Million 48.78 Million 51.12 Million 52.6 Million 52.6 Million 52.6 Million
Long-Term Investments 756 Thousand 524 Thousand 581 Thousand 455 Thousand 244 Thousand 77 Thousand
Tax Assets 195 Thousand 183 Thousand 173 Thousand 165 Thousand 283 Thousand 272 Thousand
Other Non Current Assets - - - -1.00 - -52.94 Million
Other Assets - - - 1.00 1.00 52.97 Million
Total Liabilities 59.07 Million 59.12 Million 53.98 Million 35.6 Million 30.39 Million 15.14 Million
Total Current Liabilities 18.79 Million 16.26 Million 16.76 Million 14.12 Million 14.33 Million 9.07 Million
Account Payables 6.36 Million 4.56 Million 2.95 Million 7.38 Million 4.28 Million 6.55 Million
Tax Payables 20 Thousand 21 Thousand 14 Thousand 2000.00 20 Thousand 86 Thousand
Short Term Debt 7.26 Million 3.97 Million 2.36 Million 644 Thousand 857 Thousand 628 Thousand
Deferred Revenue 347 Thousand 812 Thousand 1.04 Million 1.08 Million 4.81 Million 574 Thousand
Other Current Liabilities 4.83 Million 6.91 Million 10.39 Million 5 Million 4.37 Million 1.31 Million
Total Non Current Liabilities 40.28 Million 42.85 Million 37.22 Million 21.48 Million 16.06 Million 3.83 Million
Long-Term Debt 35.5 Million 37.23 Million 30.8 Million 16.55 Million 9.21 Million 3.83 Million
Deferred Revenue Non Current 3.03 Million 3.58 Million 3.96 Million 2.31 Million 1.41 Million 1.82 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 429 Thousand 524 Thousand 710 Thousand 531 Thousand 377 Thousand -3.83 Million
Other Liabilities - - - - - 2.24 Million
Total Equity 22.82 Million 32.54 Million 47.53 Million 61.23 Million 58.49 Million 61.75 Million
Stock Holders Equity 22.82 Million 32.54 Million 47.53 Million 61.23 Million 58.49 Million 61.75 Million
Common Stock 4.33 Million 3.7 Million 3.7 Million 3.59 Million 3 Million 2.96 Million
Retained Earnings -57.28 Million -35.88 Million -21.11 Million -7.48 Million 34.11 Million 5.49 Million
Accumulated other comprehensive income -309 Thousand -220 Thousand -150 Thousand -104 Thousand -100 Thousand -57 Thousand
Common Stock Equity 22.82 Million 32.54 Million 47.53 Million 61.23 Million 58.49 Million 61.75 Million
Capital Lease Obligation 3.03 Million 3.58 Million 3.96 Million 2.31 Million 1.41 Million -
Total Investments 756 Thousand 524 Thousand 581 Thousand 455 Thousand 244 Thousand 2.86 Million
Total Debt 45.8 Million 44.79 Million 37.13 Million 19.51 Million 11.48 Million 4.46 Million
Net Debt 27.12 Million 19.17 Million 3.55 Million -9.85 Million -14.36 Million -5.11 Million

Balance Sheet Charts